Hepcvilr-L (ledipasvir 90mg & Sofosbuvir 400mg) View larger

Hepcvir-L (ledipasvir 90mg /Sofosbuvir 400mg)

New product

$229.00

$229.00 per 28 Tablets

Indications & Dosage

Hepcvir L, also known as Hepcinat-LP, Myhep lvir” is a fixed-dose combination of Sofosbuvir and Ledipasvir indicated for the treatment of chronic hepatitis C virus (HCV). Hepcvilr L combines Sofosbuvir 400mg and Ledipasvir90mg. Its Cure rates is 94% to 99% for hepatitis C.

Hepcvilr L is a generic prescription medicine from Cipla, which is one of the biggest pharmaceutical company in India.

Hepcvir-L Dosage:

For the treatment of chronic hepatitis C infection.
For the treatment of chronic hepatitis C virus (HCV) genotype 1 infection.
Oral dosage
Treatment-naive Adults without cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks; however, an 8-week treatment duration can be considered for those patients with a baseline hepatitis C virus RNA less than 6 million international units/mL. Recommendation includes patients coinfected with HIV.

Treatment-naive Adults with compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks. Recommendation includes patients coinfected with HIV.

Treatment-experienced Adults without cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks. Recommendation includes patients coinfected with HIV.

Treatment-experienced Adults with compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 24 weeks. Alternatively, treatment duration may be reduced to 12 weeks if ledipasvir; sofosbuvir is administered in combination with ribavirin. Ribavirin must be administered with food in 2 divided doses, and the dose is based on weight as follows: less than 75 kg give 500 mg PO twice daily; 75 kg or more give 600 mg PO twice daily. Recommendation includes patients coinfected with HIV.

Treatment-naive and experienced Adults with decompensated (Child-Pugh B or C) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with ribavirin (600 mg PO once daily) for 12 weeks. Ribavirin must be administered with food, and if tolerated, the dose may be increased as follows: if less than 75 kg give 500 mg PO twice daily; if 75 kg or more give 600 mg PO twice daily. Consider decreasing ribavirin dose for abnormal hemoglobin. Recommendation includes patients coinfected with HIV. For patients unable to take ribavirin, guidelines recommend 1 tablet PO once daily for 24 weeks.

Treatment-naive and experienced Adults who have undergone liver transplantation and are without cirrhosis or have compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with ribavirin for 12 weeks. Ribavirin must be administered with food in 2 divided doses, and the dose is based on weight as follows: less than 75 kg give 500 mg PO twice daily; 75 kg or more give 600 mg PO twice daily. Recommendation includes patients coinfected with HIV.

Treatment-naive and experienced Adults who have undergone liver transplantation and have decompensated (Child-Pugh B or C) cirrhosis†

Guidelines recommend 1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with low initial dose of ribavirin for 12 weeks as the preferred regimen. Increase ribavirin dose as tolerated.

Treatment-naive Children and Adolescents 12 to 17 years without cirrhosis or with compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks. Recommendation includes patients coinfected with HIV. 

Treatment-experienced Children and Adolescents 12 to 17 years without cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks. Recommendation includes patients coinfected with HIV. 

Treatment-experienced Children and Adolescents 12 to 17 years with compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 24 weeks. Recommendation includes patients coinfected with HIV. 

Treatment-naive Children younger than 12 years weighing at least 35 kg without cirrhosis or with compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks. Recommendation includes patients coinfected with HIV. 

Treatment-experienced Children younger than 12 years weighing at least 35 kg without cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks. Recommendation includes patients coinfected with HIV. 

Treatment-experienced Children younger than 12 years weighing at least 35 kg with compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 24 weeks. Recommendation includes patients coinfected with HIV. 

For the treatment of chronic hepatitis C virus (HCV) genotypes 5 or 6 infection.
Oral dosage
Treatment-naive and experienced Adults without cirrhosis or who have compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks. Recommendation includes patients coinfected with HIV.

Treatment-naive and experienced Adults with decompensated (Child-Pugh B or C) cirrhosis†

Guidelines recommend 1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with low initial dose of ribavirin for 12 weeks as a preferred regimen. Increase ribavirin dose as tolerated. For patients unable to take ribavirin, guidelines recommend 1 tablet PO once daily for 24 weeks.

Treatment-naive and experienced Adults who have undergone liver transplantation and are without cirrhosis or have compensated (Child-Pugh A) cirrhosis†

Guidelines recommend 1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with weight-based ribavirin for 12 weeks as a preferred regimen.

Treatment-naive and experienced Adults who have undergone liver transplantation and have decompensated (Child-Pugh B or C) cirrhosis†

Guidelines recommend 1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with low initial dose of ribavirin for 12 weeks as the preferred regimen. Increase ribavirin dose as tolerated.

Treatment-naive and experienced Children and Adolescents 12 to 17 years without cirrhosis or who have compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks. Recommendation includes patients coinfected with HIV. 

Treatment-naive and experienced Children younger than 12 years weighing at least 35 kg without cirrhosis or who have compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks. Recommendation includes patients coinfected with HIV. 

For the treatment of chronic hepatitis C virus (HCV) genotype 4 infection.
Oral dosage
Treatment-naive and experienced Adults without cirrhosis or who have compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks. Recommendation includes patients coinfected with HIV.

Treatment-naive and experienced Adults with decompensated (Child-Pugh B or C) cirrhosis†

Guidelines recommend 1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with low initial dose of ribavirin for 12 weeks as a preferred regimen. Increase ribavirin dose as tolerated. For patients unable to take ribavirin, guidelines recommend 1 tablet PO once daily for 24 weeks.

Treatment-naive and experienced Adults who have undergone liver transplantation and are without cirrhosis or have compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with ribavirin for 12 weeks. Ribavirin must be administered with food in 2 divided doses, and the dose is based on weight as follows: less than 75 kg give 500 mg PO twice daily; 75 kg or more give 600 mg PO twice daily. Recommendation includes patients coinfected with HIV.

Treatment-naive and experienced Adults who have undergone liver transplantation and have decompensated (Child-Pugh B or C) cirrhosis†

Guidelines recommend 1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with low initial dose of ribavirin for 12 weeks as the preferred regimen. Increase ribavirin dose as tolerated.

Treatment-naive and experienced Children and Adolescents 12 to 17 years without cirrhosis or who have compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks. Recommendation includes patients coinfected with HIV. 

Treatment-naive and experienced Children younger than 12 years weighing at least 35 kg without cirrhosis or who have compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks. Recommendation includes patients coinfected with HIV. 

Hepcvir-L Side Effects:

Hepatitis B virus reactivation: Before starting treatment with Hepcinat-LP, your healthcare provider will do blood tests to check for hepatitis B virus infection. If you have ever had hepatitis B virus infection, the hepatitis B virus could become active again during or after treatment of hepatitis C virus with Hepcvir-L. Hepatitis B virus becoming active again (called reactivation) may cause serious liver problems including liver failure and death. Your healthcare provider will monitor you if you are at risk for hepatitis B virus reactivation during treatment and after you stop taking 

Hepcvir-L PI

For more Prescribing information，please ask for “ Prescribing Information” from our customer supporter.

Additional Info

Package Quantity28
WarningsDon't take the drug without consulting a qualified doctor or physician
Suggested useFollow the doctor's advice
Delivery & Returns7-14 Days

Reviews

Grade 
2018-01-05 03:23:31
Thank you

I am on my first week, I have had this infection since 2016 when I was diagnosed. I am very excited to be PURE AGAIN, Completing this will be another success for me and only make me a stronger person. I have to say I feel really weak and have fatigue, I drink a whole lot of water and some Protein shakes during my day. Thanks Bonhoa Pharmacy.

    Grade 
    2017-12-08 09:14:51
    God bless you

    God bless Bonhoa Pharmacy!! After 6 months...I AM CURED!!! I even had no noticeable side effect what so ever.

      Grade 
      2017-12-04 03:37:29
      ITS THE BEST FEELING

      6 days into 8 weeks. So far, no side effects. Nothing worse than what I've been experiencing for the past few years without treatment. I had to chose Indian generic drugs. My mother has been concerned about my poor appetite for the past 5 years. I actually have a more positive outlook on the future. Now that this journey has begun ITS THE BEST FEELING! Thanks Bonhoa Pharmacy give NEW HOPE!

        Write your review!

        Write a review

        Hepcvir-L (ledipasvir 90mg /Sofosbuvir 400mg)

        Hepcvir-L (ledipasvir 90mg /Sofosbuvir 400mg)

        Ledipasvir 90mg/Sofosbuvir 400mg

        Accessories

        30 other products in the same category:

        Related products

        SiteLock